{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-049761","form_type":"8-K","ticker":"DOMH","cik":"0000012239","company_name":"Dominari Holdings Inc.","filed_at":"2022-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.165689+00:00","generated_at":"2026-06-23T22:28:03.355425+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AIkido Pharma receives unsolicited $8.00/share acquisition proposal, board rejects it","bullets":["Shalom Auerbach proposed to acquire all outstanding shares for $8.00 per share in cash.","Board reviewed the offer and sent a letter on August 18, 2022, declining the proposal.","No reasons for rejection or further details were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-049761","json":"https://secwatch.observer/filing/0001213900-22-049761.json","markdown":"https://secwatch.observer/filing/0001213900-22-049761.md","text":"https://secwatch.observer/filing/0001213900-22-049761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12239/000121390022049761/0001213900-22-049761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12239/000121390022049761/ea164743-8k_aikido.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T22:28:03.355425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}